Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Maria Teresa Bianco"'
Autor:
Raffaela Olivieri, Paola Vannini, Alice Corzani, Maria Teresa Bianco, Federico Franchi, Maria Grazia Cusi, Sabino Scolletta, Fabio Arena, Claudia Basagni, Roberto Gusinu, Mario Tumbarello
Publikováno v:
Antibiotics, Vol 12, Iss 4, p 694 (2023)
Fluoroquinolones (FQs) represent an class of antibiotics of medical importance, but their use has been restricted due to their ecologic impact and associated side effects. The reduction of FQs use is an important goal of antimicrobial stewardship pro
Externí odkaz:
https://doaj.org/article/5ac0dca803374d5caf2d483aa92d5af1
Autor:
Claudia Fabiani, Antonio Vitale, Giacomo Emmi, Arianna Sgheri, Giuseppe Lopalco, Jurgen Sota, Silvana Guerriero, Florenzo Iannone, Bruno Frediani, Lorenzo Vannozzi, Maria Teresa Bianco, Valtere Giovannini, Gian Marco Tosi, Luca Cantarini
Publikováno v:
Frontiers in Pharmacology, Vol 10 (2019)
Background: Recent expiry of patents for tumor necrosis factor (TNF)-α inhibitors has led to the employment of biosimilars in clinical practice. The aim of the study was to identify any change in the control of ocular inflammatory manifestations amo
Externí odkaz:
https://doaj.org/article/a29b39455dae40c8afaf65ab5f6496f4
Autor:
Claudia Fabiani, Antonio Vitale, Giuseppe De Bartolo, Jurgen Sota, Carla Gaggiano, Stefano Gentileschi, Bruno Frediani, Luca Cantarini, Gian Marco Tosi, Maria Teresa Bianco
Publikováno v:
Asia-Pacific journal of ophthalmology (Philadelphia, Pa.). 10(4)
PURPOSE Several concerns have arisen with biosimilars in terms of immunogenicity, safety issues, loss of efficacy, and extrapolation to other indications. The study aim was to evaluate the efficacy of SB5, an adalimumab biosimilar, in noninfectious u
Autor:
Bruno Frediani, Claudia Fabiani, Antonio Vitale, Valtere Giovannini, Arianna Sgheri, Maria Teresa Bianco, Lorenzo Vannozzi, Florenzo Iannone, Jurgen Sota, Giacomo Emmi, Luca Cantarini, Giuseppe Lopalco, Silvana Guerriero, Gian Marco Tosi
Publikováno v:
Frontiers in Pharmacology
Frontiers in Pharmacology, Vol 10 (2019)
Frontiers in Pharmacology, Vol 10 (2019)
Background: Recent expiry of patents for tumor necrosis factor (TNF)-α inhibitors has led to the employment of biosimilars in clinical practice. The aim of the study was to identify any change in the control of ocular inflammatory manifestations amo
Autor:
Giuseppe Lopalco, Luca Cantarini, Giacomo Emmi, Mauro Galeazzi, Donato Rigante, Maria Teresa Bianco, Antonio Vitale, Florenzo Iannone
Publikováno v:
Expert Opinion on Investigational Drugs. 25:827-840
Behçet's syndrome (BS) is a systemic inflammatory disorder characterized by a wide range of potential clinical manifestations with no gold-standard therapy. However, the recent classification of BS at a crossroads between autoimmune and autoinflamma